
MaaT Pharma Investor Relations Material
Latest events

KOL Event
MaaT Pharma

H2 2024
26 Mar, 2025

Corporate Presentation
8 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from MaaT Pharma SA
Access all reports
MaaT Pharma SA is a biotechnology company specializing in the development of microbiome-based therapies for the treatment of diseases related to immune and gastrointestinal disorders. The company focuses on restoring gut microbiota balance to support patient health, particularly in areas such as oncology and infectious diseases. MaaT Pharma utilizes a proprietary research platform to develop therapeutic solutions, including biotherapeutic products derived from microbiota. The company is engaged in clinical research and collaborates with healthcare institutions and industry partners to advance its pipeline. MaaT Pharma is headquartered in Lyon, France, and its shares are listed on the Euronext.
Key slides for MaaT Pharma SA


KOL Event
MaaT Pharma SA


Corporate Presentation
MaaT Pharma SA
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
MAAT
Country
🇫🇷 France